SLIT2-IT1 expression was markedly decreased (P = 0.030, Fig. 4a), whereas miR-218 expression was nearly undetectable in CML patients. This evidence concerns the gene SLIT2 and chronic myelogenous leukemia, BCR-ABL1 positive.